Skip to main content
Clinical Trials/TCTR20240708004
TCTR20240708004
Not yet recruiting
Phase 3

Efficacy of intravenous lidocaine infusion for postoperative quality of recovery in laparoscopic gynecological surgery : A triple-blind, randomized controlled trial

Rajavithi Hospital0 sites64 target enrollmentJuly 8, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Quality of recoveryPostoperative painPostoperative nausea and vomiting
Sponsor
Rajavithi Hospital
Enrollment
64
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2024
End Date
June 30, 2025
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who scheduled for elective laparoscopic gynecological surgery for benign diseases
  • 2\. ASA physical status 1\-2

Exclusion Criteria

  • 1\. Pregnancy
  • 2\. Body weight \< 40 kg or BMI \> 35 kg/m2
  • 3\. History of local anesthetic allergy
  • 4\. History of cardiac arrhythmia
  • 5\. Cirrhosis or elevated AST or ALT \>/\= 2x of normal upper limit
  • 6\. GFR \</\= 60 ml/min/1\.73m2
  • 7\. Neurological disease
  • 8\. NSAID or sulfa drugs allergy
  • 9\. History of GI bleeding or peptic ulcer
  • 10\. Regular use of analgesics

Outcomes

Primary Outcomes

Not specified

Similar Trials